Trial
NCT04305678
Mepolizumab for Eosinophilic Fasciitis
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
GlaxoSmithKline
Condition
Eosinophilic Fasciitis
Intervention
Mepolizumab
Why stopped
Funding lost from Sponsor.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-20